|
|
№3 (приложение) / 2023
|
|
|
№3 (приложение) / 2023
|
|
Borovkova N.Yu., Kurashin V.K., Tokareva A.S., Makarova E.V., Nekrasov A.A., Savitskaya N.N., Mironov M.A.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
|
№3 / 2023
|
|
Reznik E.V., Golubev Yu.Yu., Zhuravlev A.K., Yurtaeva N.V., Ischenko G.Yu.
Arterial hypertension and longevity
|
№10 / 2022
|
|
Glibko K.V., Arakelov S.E., Titova I.Yu., Kasaeva D.A., Larina V.N.
Peculiarities of cardiovascular outcomes in male and female patients after novel coronavirus infection caused by SARS-CoV-2
|
№9 / 2022
|
|
Podorozhnyuk K.V., Skuridina D.V.
The importance of a multifactorial approach in the treatment of type 2 diabetes mellitus: clinical cases
|
№8 / 2022
|
|
Demidova T.Yu., Izmailova M.Ya.
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care
|
№8 / 2022
|
|
Khlynova O.V., Stepina E.A., Trapeznikova A.A.
Inflammatory bowel diseases and cardiovascular pathology: pathogenetic correlations and age-related peculiarities
|
№7 / 2022
|
|
Alieva A.M., Teplova N.V., Ettinger O.A., Reznik E.V., Baykova I.E., Sarakaeva L.R., Shnahova L.M., Arakelyan R.A., Valiev R.K., Nikitin I.G.
The role of interleukin 12 in the development of cardiovascular diseases
|
№6 / 2022
|
|
Alieva A.M., Reznik E.V., Teplova N.V., Totolyan G.G., Gasanova E.T., Kalova M.R., Sabanchieva E.E., Nikitin I.G.
JDP2 – a new promising biological marker in cardiovascular pathology
|
№5 / 2022
|
|
Yesina E.Yu., Zuikova A.A., Kotova Yu.A.
The relationship of environmental risk factors and cardiovascular diseases in hypertensive patients living in rural areas
|
№4 (приложение) / 2022
|
|
Aliev A.M., Reznik E.V., Teplova N.V., Arakelyan R.A., Shnahova L.M., Baykova I.E., Akkieva M.A., Nikitin I.G.
Interleukin 37 is a new biological marker for cardiovacular pathology
|
№4 / 2022
|
Русский
